At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Active Neuronetics rTMS stimulator +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
rTMS in Treatment Resistant Depression
In Brief
A clinical study evaluating Active Neuronetics rTMS stimulator and Inactive Neuronetics rTMS stimulator for Depression. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the safety and efficacy of rTMS as an alternative treatment to ECT. The study will also provide data for a power analysis to support a larger clinical trial if there is evidence of a clinically relevant treatment effect.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMar 2014
First PostedMar 2014
Primary CompletionDec 2015
TodayJul 2026
First PostedMar 6, 2014
Enrollment StartMar 1, 2014
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 12.3 years ago
Interventions
Active Neuronetics rTMS stimulatordevice
In the active group, magnetic power output will be delivered to the subject through the coils.
Inactive Neuronetics rTMS stimulatordevice
In the inactive group, no magnetic power output will be delivered to the subject through the coils.